These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16301192)

  • 21. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualizing osteoporosis therapy.
    Silverman S; Christiansen C
    Osteoporos Int; 2012 Mar; 23(3):797-809. PubMed ID: 22218417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New treatments in osteoporosis].
    Chapurlat R; Delmas PD
    Rev Med Interne; 2004 Dec; 25 Suppl 5():S573-9. PubMed ID: 15841950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF; Geusens P
    Curr Opin Rheumatol; 2014 May; 26(3):245-51. PubMed ID: 24625372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring strontium ranelate therapy in patients with osteoporosis.
    Kendler DL; Adachi JD; Josse RG; Slosman DO
    Osteoporos Int; 2009 Jul; 20(7):1101-6. PubMed ID: 19266136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and prevention of osteoporosis.
    Blahos J
    Wien Med Wochenschr; 2007; 157(23-24):589-92. PubMed ID: 18204959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in the treatment of osteoporosis.
    Eriksen EF; Halse J; Moen MH
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate: a look back at its use for osteoporosis.
    Reginster JY; Neuprez A
    Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anti-osteoporosis medications on fracture healing.
    Jørgensen NR; Schwarz P
    Curr Osteoporos Rep; 2011 Sep; 9(3):149-55. PubMed ID: 21698357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
    Hiligsmann M; Vanoverberghe M; Neuprez A; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of bone mineral density changes with denosumab compared with other drugs in postmenopausal osteoporosis: a dose-response-based meta-analysis.
    Mandema JW; Zheng J; Libanati C; Perez Ruixo JJ
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3746-55. PubMed ID: 24915115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and emerging treatments for osteoporosis.
    Maricic M
    Curr Opin Rheumatol; 2007 Jul; 19(4):364-9. PubMed ID: 17551368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strontium ranelate for osteoporosis?
    Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Strontium ranelate (Osseor)--unique double mechanism--physiologic bone treatment as live tissue].
    Novak S
    Reumatizam; 2007; 54(2):83-4. PubMed ID: 18351151
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential anti-catabolic and anabolic properties of strontium ranelate.
    Mentaverri R; Brazier M; Kamel S; Fardellone P
    Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
    Fassbender WJ; Stumpf UC
    Z Rheumatol; 2006 Sep; 65(5):364-6, 368-9. PubMed ID: 16947038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.